We demonstrated previously that SRI31215 effectively inhibits HGF-dependent MET activation, proliferation, epithelial-mesenchymal transition and migration of cancer cells and overcomes fibroblast-mediated resistance to EGFR inhibitors in colon cancer cells [36]. This evidence concerns the gene HGF and cancer.